Table 3.
The influence of high-dose vitamin D3 therapy on adipocytokines and inflammatory markers in Protocol 1.
| Before Vitamin D3 Intervention | After Vitamin D3 Intervention | P-value | |
|---|---|---|---|
| Fasting glucose (mg/dL) | 93.4 ± 2.07 | 93.4 ± 2.03 | 0.99 |
| Fasting insulin (μIU/mL) | 7.63 ± 1.02 | 10.49 ± 1.85 | 0.11 |
| HOMA-IR | 1.77 ± 0.25 | 2.47 ± 0.46 | 0.14 |
| IL-6 (pg/mL) | 4.66 ± 1.18 | 4.08 ± 0.86 | 0.76 |
| PAI-1 (ng/mL) | 5.17 ± 0.71 | 5.81 ± 0.90 | 0.51 |
| Urinary TGFβ1/Urine Creatinine (μg/dL) | 94.2 ± 12.0 | 108.3 ± 18.4 | 0.48 |
| Adiponectin (μg/mL) | 3.87 ± 0.53 | 3.57 ± 0.40 | 0.28 |
| Resistin (μg/L) | 5.80 ± 0.35 | 5.98 ± 0.49 | 0.53 |
| Leptin (ng/mL) | 41.11 ± 6.52 | 42.71 ± 7.58 | 0.42 |
Table displays mean values (± standard error of means) before and after vitamin D3 intervention.